Pfizer lowers 2018 revenue forecast, increases R&D spend

Pfizer Inc lowered its revenue forecast for this year, blaming the stronger dollar, and increased its planned spending on research and development, as the drugmaker works to launch new drugs to replace declining sales from its established products like Viagra.

…read more

Source:: Reuters – Business News

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.